Full list of author information is available at the end of the articleHepatitis B virus (HBV) infection is a significant global health problem. An estimated two billion people world-wide have been infected with the hepatitis B virus and more than 240 million have chronic liver infections. About 600000 people die every year due to the acute or chronic consequences of hepatitis B [1]. The prevalence in China is high and includes an estimated 120 million with HBV, with a prevalence as high as 7.9 % [2,3]. Chronic hepatitis B (CHB) increased the risk of liver fail-ure and hepatocellular carcinoma. It imposes consider-able economic burden on a family [4]. The incidence rate of hepatitis B ranks first, and the mortality rate ranks third, among al...